FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 346:524-526 February 14, 2002 Number 7 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Editorial by Drazen, J. M. Letters Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article Related Article by Rosenthal, M. B. Related Article by Lee, T. H. PubMed Citation

During the past two decades, there has been an irreversible change in the nature of the doctor–patient relationship. Patients are seeking much more medical information and are actively participating in decisions affecting their health. Intruding into this trend has been the rise of direct-to-consumer promotion, which, in its initial thrust, bypasses primary care doctors and other physicians. Although increased access by patients to accurate, objective information about tests to diagnose and drugs to treat illnesses is an important advance, confusion arises when commercially driven promotional information is represented as educational. Two articles in this issue of the Journal address the . . . [Full Text of this Article]

References

Related Letters:

Malposition of a Pacemaker Lead
Farzaneh-Far A., Firschke C., Zrenner B., Kastrati A.
Extract | Full Text | PDF  
N Engl J Med 2002; 346:2010, Jun 20, 2002. Correspondence

Direct-to-Consumer Marketing
Weinberg S. K., Ackman D., Glied S., Nunes J. P. L., Hurst J. W., Ehrlich J. E., Rumberger J. A., Wasserman A. G., Rosenthal M., Frank R. G., Epstein A. M., Lee T. H., Brennan T. A., Wolfe S. M.
Extract | Full Text | PDF  
N Engl J Med 2002; 346:2010-2013, Jun 20, 2002. Correspondence

This article has been cited by other articles:

• Donohue, J. M., Cevasco, M., Rosenthal, M. B. (2007). A Decade of Direct-to-Consumer Advertising of Prescription Drugs. NEJM 357: 673-681 [Abstract] [Full Text]  
• Jagsi, R. (2007). Conflicts of Interest and the Physician-Patient Relationship in the Era of Direct-to-Patient Advertising. JCO 25: 902-905 [Full Text]  
• Frosch, D. L., Krueger, P. M., Hornik, R. C., Cronholm, P. F., Barg, F. K. (2007). Creating Demand for Prescription Drugs: A Content Analysis of Television Direct-to-Consumer Advertising. Ann Fam Med 5: 6-13 [Abstract] [Full Text]  
• Gilbody, S, Wilson, P, Watt, I (2005). Benefits and harms of direct to consumer advertising: a systematic review. Qual Saf Health Care 14: 246-250 [Abstract] [Full Text]  
• Callaghan, J. J., Crowninshield, R. D., Greenwald, A. S., Lieberman, J. R., Rosenberg, A. G., Lewallen, D. G. (2005). Symposium: Introducing Technology into Orthopaedic Practice. How Should It Be Done?. JBJS 87: 1146-1158 [Full Text]  
• Larson, R. J., Schwartz, L. M., Woloshin, S., Welch, H. G. (2005). Advertising by Academic Medical Centers. Arch Intern Med 165: 645-651 [Abstract] [Full Text]  
• Illes, J., Kann, D., Karetsky, K., Letourneau, P., Raffin, T. A., Schraedley-Desmond, P., Koenig, B. A., Atlas, S. W. (2004). Advertising, Patient Decision Making, and Self-referral for Computed Tomographic and Magnetic Resonance Imaging. Arch Intern Med 164: 2415-2419 [Abstract] [Full Text]  
• Waack, K. E, Ernst, M. E, Graber, M. A (2004). Informational Content of Official Pharmaceutical Industry Web Sites about Treatments for Erectile Dysfunction. The Annals of Pharmacotherapy 38: 2029-2034 [Abstract] [Full Text]  
• Husain, M. (2004). Pharmaceutical influence and psychiatrists: an introspection. Br. J. Psychiatry 185: 354-354 [Full Text]  
• Gilbody, S., Wilson, P., Watt, I. (2004). Direct-to-consumer advertising of psychotropics: An emerging and evolving form of pharmaceutical company influence. Br. J. Psychiatry 185: 1-2 [Full Text]  
• Kaphingst, K. A., DeJong, W. (2004). The Educational Potential Of Direct-To-Consumer Prescription Drug Advertising. Health Aff (Millwood) 23: 143-150 [Abstract] [Full Text]  
• Schwartz, L. M., Woloshin, S., Fowler, F. J. Jr, Welch, H. G. (2004). Enthusiasm for Cancer Screening in the United States. JAMA 291: 71-78 [Abstract] [Full Text]  
• Gray, S., Olopade, O. I. (2003). Direct-to-Consumer Marketing of Genetic Tests for Cancer: Buyer Beware. JCO 21: 3191-3193 [Full Text]  
• Maynard, A., Bloor, K. (2003). Dilemmas In Regulation Of The Market For Pharmaceuticals. Health Aff (Millwood) 22: 31-41 [Abstract] [Full Text]  
• Gollust, S. E., Hull, S. C., Wilfond, B. S. (2002). Limitations of Direct-to-Consumer Advertising for Clinical Genetic Testing. JAMA 288: 1762-1767 [Abstract] [Full Text]  
• Weinberg, S. K., Ackman, D., Glied, S., Nunes, J. P. L., Hurst, J. W., Ehrlich, J. E., Rumberger, J. A., Wasserman, A. G., Rosenthal, M., Frank, R. G., Epstein, A. M., Lee, T. H., Brennan, T. A., Wolfe, S. M. (2002). Direct-to-Consumer Marketing. NEJM 346: 2010-2013 [Full Text]  
• Drazen, J. M. (2002). The Consumer and the Learned Intermediary in Health Care. NEJM 346: 523-524 [Full Text]